Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda

Table 2 Patient categories by gender

Participant category	Participants interviewed
Participant category	Male	Female
Participants stable on DTG (SOD)	5	5
Participants who experienced side effects (ESE)	3	2
Women of reproductive age on DTG (RSD)	0	5
Women of reproductive age off DTG (RSOD)	0	5
Total	8	17

Some patient categories overlap due to multiple experiences. Some participants were peer experts who had participated in switch decision meetings as well as participants of high economic status who attended the IDI-Co-pay evening clinic

ISSN: 1471-2334